[go: up one dir, main page]

MX2009005649A - Tratamiento para mieloma multiple. - Google Patents

Tratamiento para mieloma multiple.

Info

Publication number
MX2009005649A
MX2009005649A MX2009005649A MX2009005649A MX2009005649A MX 2009005649 A MX2009005649 A MX 2009005649A MX 2009005649 A MX2009005649 A MX 2009005649A MX 2009005649 A MX2009005649 A MX 2009005649A MX 2009005649 A MX2009005649 A MX 2009005649A
Authority
MX
Mexico
Prior art keywords
multiple myeloma
treatment
subject
administering
treating
Prior art date
Application number
MX2009005649A
Other languages
English (en)
Inventor
Michel Dreano
Michel Jourdan
Bernard Klein
Original Assignee
Ares Trading Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading Sa filed Critical Ares Trading Sa
Publication of MX2009005649A publication Critical patent/MX2009005649A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención provee métodos para tratar a un sujeto que sufre de mieloma múltiple, que comprenden administrar al sujeto una cantidad efectiva de un compuesto de conformidad con la fórmula I. (ver fórmula (I)).
MX2009005649A 2006-11-27 2007-11-27 Tratamiento para mieloma multiple. MX2009005649A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US86112006P 2006-11-27 2006-11-27
US90413807P 2007-02-28 2007-02-28
PCT/EP2007/010299 WO2008064866A1 (en) 2006-11-27 2007-11-27 Treatment for multiple myeloma

Publications (1)

Publication Number Publication Date
MX2009005649A true MX2009005649A (es) 2009-06-08

Family

ID=39157918

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009005649A MX2009005649A (es) 2006-11-27 2007-11-27 Tratamiento para mieloma multiple.

Country Status (12)

Country Link
US (1) US20100069316A1 (es)
EP (1) EP2139482B1 (es)
JP (1) JP2010510971A (es)
KR (1) KR20090093965A (es)
AT (1) ATE533489T1 (es)
AU (1) AU2007324850A1 (es)
CA (1) CA2669128C (es)
EA (1) EA200970512A1 (es)
ES (1) ES2377717T3 (es)
IL (1) IL198901A0 (es)
MX (1) MX2009005649A (es)
WO (1) WO2008064866A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5713367B2 (ja) 2010-06-04 2015-05-07 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ Ｌｒｒｋ２モジュレーターとしてのアミノピリミジン誘導体
BR112013011600B1 (pt) 2010-11-10 2022-01-11 Genentech, Inc Derivados de pirazol aminopirimidina, seu uso e composição que os compreende
AU2012250491A1 (en) * 2011-05-02 2013-05-02 Ym Biosciences Australia Pty Ltd Multiple myeloma treatment
KR102475758B1 (ko) * 2012-04-13 2022-12-07 에피자임, 인코포레이티드 암 치료용 병용 요법
KR101471273B1 (ko) * 2013-01-29 2014-12-11 인제대학교 산학협력단 Ｓｏｄ２를 포함하는 보르테조밉 내성 진단용 바이오 마커 조성물 및 이를 이용한 진단 키트
US11066404B2 (en) 2018-10-11 2021-07-20 Incyte Corporation Dihydropyrido[2,3-d]pyrimidinone compounds as CDK2 inhibitors
US11384083B2 (en) 2019-02-15 2022-07-12 Incyte Corporation Substituted spiro[cyclopropane-1,5′-pyrrolo[2,3-d]pyrimidin]-6′(7′h)-ones as CDK2 inhibitors
TW202100520A (zh) 2019-03-05 2021-01-01 美商英塞特公司 作為cdk2 抑制劑之吡唑基嘧啶基胺化合物
WO2020205560A1 (en) 2019-03-29 2020-10-08 Incyte Corporation Sulfonylamide compounds as cdk2 inhibitors
WO2020223469A1 (en) 2019-05-01 2020-11-05 Incyte Corporation N-(1-(methylsulfonyl)piperidin-4-yl)-4,5-di hydro-1h-imidazo[4,5-h]quinazolin-8-amine derivatives and related compounds as cyclin-dependent kinase 2 (cdk2) inhibitors for treating cancer
US11447494B2 (en) 2019-05-01 2022-09-20 Incyte Corporation Tricyclic amine compounds as CDK2 inhibitors
AU2020328025A1 (en) 2019-08-14 2022-03-03 Incyte Corporation Imidazolyl pyrimidinylamine compounds as CDK2 inhibitors
CN119930611A (zh) 2019-10-11 2025-05-06 因赛特公司 作为cdk2抑制剂的双环胺
US11981671B2 (en) 2021-06-21 2024-05-14 Incyte Corporation Bicyclic pyrazolyl amines as CDK2 inhibitors
US11976073B2 (en) 2021-12-10 2024-05-07 Incyte Corporation Bicyclic amines as CDK2 inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7618630B2 (en) * 1998-09-14 2009-11-17 Board Of Regents, The University Of Texas System Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists
US7129242B2 (en) * 2000-12-06 2006-10-31 Signal Pharmaceuticals, Llc Anilinopyrimidine derivatives as JNK pathway inhibitors and compositions and methods related thereto
EP1364949A4 (en) * 2001-02-02 2005-11-23 Takeda Pharmaceutical JNK INHIBITOR
US6864047B2 (en) * 2001-03-29 2005-03-08 Mayo Foundation For Medical Education And Research IL1-β: a new target for myeloma therapy
WO2002092573A2 (en) * 2001-05-16 2002-11-21 Vertex Pharmaceuticals Incorporated Heterocyclic substituted pyrazoles as inhibitors of src and other protein kinases

Also Published As

Publication number Publication date
EP2139482A1 (en) 2010-01-06
ES2377717T3 (es) 2012-03-30
CA2669128C (en) 2011-07-12
EA200970512A1 (ru) 2009-12-30
EP2139482B1 (en) 2011-11-16
AU2007324850A1 (en) 2008-06-05
WO2008064866A1 (en) 2008-06-05
WO2008064866A8 (en) 2008-10-02
IL198901A0 (en) 2010-02-17
AU2007324850A2 (en) 2009-07-02
ATE533489T1 (de) 2011-12-15
JP2010510971A (ja) 2010-04-08
KR20090093965A (ko) 2009-09-02
US20100069316A1 (en) 2010-03-18
CA2669128A1 (en) 2008-06-05

Similar Documents

Publication Publication Date Title
MX2009005649A (es) Tratamiento para mieloma multiple.
EA201300860A1 (ru) Кристаллические трипептидные ингибиторы эпоксикетон-протеазы
MX2009007075A (es) Metodos de uso para analogos de ciclopamina.
TW200744586A (en) Therapeutic compounds
TN2011000291A1 (en) Purine compounds
MX2009009699A (es) Compuestos amino-5-[4-(difluorometoxi)fenil sustituidos]-5-fenilim idazolona como inhibidores de beta-secretasa.
EA201890768A2 (ru) Лечение злокачественной опухоли ингибиторами tor-киназы
MX2010002312A (es) Compuestos de triazolopiridina y su uso como inhibidores de cinasa reguladora de señal de apoptosis.
MY147832A (en) Compounds for enzyme inhibition
TW200626068A (en) Active compounds for seed treatment
IN2012DN03883A (es)
EA201000895A1 (ru) Композиции и способы для лечения лизосомных болезней
PH12013500913A1 (en) Substituted-quinoxaline-type-piperidine compounds and the uses thereof
MX346186B (es) Inhibidores de proteina cinasas.
MX2010008226A (es) Derivados de difluorobifenilamida para el tratamiento de hipertension ocular.
EA201170344A1 (ru) Азаиндольные ингибиторы iap
PH12013500644A1 (en) Co-crystals and salts of ccr3-inhibitors
MD20130089A2 (ro) Metodă de tratament al mielomului multiplu
BRPI0720050A2 (pt) 6-oxo-1,6-diidropirimidin-2-ilas no tratamento de doenças proliferativas
IN2012DN03846A (es)
UA104149C2 (ru) Способ защиты растений от болезней
NZ611169A (en) Pyrazole compounds having therapeutic effect on multiple myeloma
IL207250A0 (en) Sgk1 inhibitors for the prophylaxis and/or therapy of viral diseases and/or carcinomas
MX2014003883A (es) Inhibidores de monoacilglicerol lipasa para el tratamiento de enfermedades metabolicas y transtornos relacionados.
MX2010007893A (es) Sales de triazolio como inhibidores del par1, produccion de las mismas, y uso como medicamentos.